Tapewire

Nasdaq · USD

ICUI

ICU MEDICAL INC/DE

Export transactions ↓
Tapewire entity
2385
SEC CIK
0000883984
Parsed reports
427

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202608
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 16, 2017 Filed May 16, 2017 23:15 UTC Exercise / conversionCommon Stock 743 $0.00 $0.00
Disclosure

SEC source: 0001190251-17-000003 · edgardoc.xml · nonDerivative · entry 1

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,091

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
May 16, 2017 Filed May 19, 2017 18:58 UTC
Jain VivekDirector · Chairman and CEO
GiftCommon Stock 35 $0.00 $0.00
Disclosure

SEC source: 0001410442-17-000007 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,911

F1 · kind: This was a bona fide gift with no payment in consideration

F1 · price: This was a bona fide gift with no payment in consideration

Read SEC document
May 09, 2017 Filed May 10, 2017 00:05 UTC GrantNon-Qualified Stock Options (right to buy) · Derivative 1,765 $158.20 Strike: $158.20 $279,223.00
Disclosure

SEC source: 0001209191-17-031098 · doc4.xml · derivative · entry 2

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,765

Underlying: Common Stock · 1,765 shares

Expires 2027-05-09

Read SEC document
May 09, 2017 Filed May 10, 2017 00:05 UTC GrantCommon Stock · Derivative 475 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-031098 · doc4.xml · derivative · entry 1

FINNEY ELISHA W · CIK 0001217439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475

Underlying: Common Stock · 475 shares

Expires 2018-05-09

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 09, 2017 Filed May 9, 2017 23:29 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,765 $158.20 Strike: $158.20 $279,223.00
Disclosure

SEC source: 0001073391-17-000002 · edgardoc.xml · derivative · entry 2

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,765

Underlying: Common Stock · 1,765 shares

Expires 2027-05-09

Read SEC document
May 09, 2017 Filed May 9, 2017 23:29 UTC GrantCommon Stock · Derivative 475 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001073391-17-000002 · edgardoc.xml · derivative · entry 1

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475

Underlying: Common Stock · 475 shares

Expires 2018-05-09

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 09, 2017 Filed May 9, 2017 23:23 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,765 $158.20 Strike: $158.20 $279,223.00
Disclosure

SEC source: 0001073398-17-000004 · edgardoc.xml · derivative · entry 2

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,765

Underlying: Common Stock · 1,765 shares

Expires 2027-05-09

Read SEC document
May 09, 2017 Filed May 9, 2017 23:23 UTC GrantCommon Stock · Derivative 475 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001073398-17-000004 · edgardoc.xml · derivative · entry 1

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475

Underlying: Common Stock · 475 shares

Expires 2018-05-09

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 09, 2017 Filed May 9, 2017 23:19 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,765 $158.20 Strike: $158.20 $279,223.00
Disclosure

SEC source: 0001190251-17-000002 · edgardoc.xml · derivative · entry 2

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,765

Underlying: Common Stock · 1,765 shares

Expires 2027-05-09

Read SEC document
May 09, 2017 Filed May 9, 2017 23:19 UTC GrantCommon Stock · Derivative 475 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001190251-17-000002 · edgardoc.xml · derivative · entry 1

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475

Underlying: Common Stock · 475 shares

Expires 2018-05-09

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
May 09, 2017 Filed May 9, 2017 23:14 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,765 $158.20 Strike: $158.20 $279,223.00
Disclosure

SEC source: 0001645866-17-000001 · edgardoc.xml · derivative · entry 2

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,765

Underlying: Common Stock · 1,765 shares

Expires 2027-05-09

Read SEC document
May 09, 2017 Filed May 9, 2017 23:14 UTC GrantCommon Stock · Derivative 475 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001645866-17-000001 · edgardoc.xml · derivative · entry 1

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475

Underlying: Common Stock · 475 shares

Expires 2018-05-09

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:42 UTC
McGrody Kevin JController
GrantCommon Stock · Derivative 1,939 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001615192-17-000003 · edgardoc.xml · derivative · entry 1

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,939

Underlying: Common Stock · 1,939 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:37 UTC
Sanzone Virginia RuthVP, General Counsel
GrantCommon Stock · Derivative 1,778 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001669639-17-000004 · edgardoc.xml · derivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,778

Underlying: Common Stock · 1,778 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:37 UTC
Sanzone Virginia RuthVP, General Counsel
GrantCommon Stock · Derivative 1,778 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001669639-17-000004 · edgardoc.xml · derivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,778

Underlying: Common Stock · 1,778 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:22 UTC
RIGGS STEVENVP Operations
GrantCommon Stock · Derivative 1,374 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001189724-17-000004 · edgardoc.xml · derivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,374

Underlying: Common Stock · 1,374 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:22 UTC
RIGGS STEVENVP Operations
GrantCommon Stock · Derivative 1,374 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001189724-17-000004 · edgardoc.xml · derivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,374

Underlying: Common Stock · 1,374 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:02 UTC
Lamb Scott EChief Financial Officer,
GrantCommon Stock · Derivative 1,778 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001375852-17-000003 · edgardoc.xml · derivative · entry 2

Lamb Scott E · CIK 0001375852 · Chief Financial Officer,

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,778

Underlying: Common Stock · 1,778 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:02 UTC
Lamb Scott EChief Financial Officer,
GrantCommon Stock · Derivative 1,778 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001375852-17-000003 · edgardoc.xml · derivative · entry 1

Lamb Scott E · CIK 0001375852 · Chief Financial Officer,

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,778

Underlying: Common Stock · 1,778 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:06 UTC
McCall Thomas DVice President and Gen'l Mgr.
GrantCommon Stock · Derivative 1,051 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001615186-17-000003 · edgardoc.xml · derivative · entry 2

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,051

Underlying: Common Stock · 1,051 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 01:06 UTC
McCall Thomas DVice President and Gen'l Mgr.
GrantCommon Stock · Derivative 1,051 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001615186-17-000003 · edgardoc.xml · derivative · entry 1

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,051

Underlying: Common Stock · 1,051 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 00:57 UTC
Jain VivekDirector · Chairman and CEO
GrantCommon Stock · Derivative 5,978 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001410442-17-000006 · edgardoc.xml · derivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,978

Underlying: Common Stock · 5,978 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 00:57 UTC
Jain VivekDirector · Chairman and CEO
GrantCommon Stock · Derivative 5,978 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001410442-17-000006 · edgardoc.xml · derivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,978

Underlying: Common Stock · 5,978 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 00:32 UTC
BURCAR ALISON DVice President and Gen'l Mgr.
GrantCommon Stock · Derivative 1,535 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001189727-17-000004 · edgardoc.xml · derivative · entry 2

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,535

Underlying: Common Stock · 1,535 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Read SEC document
March 27, 2017 Filed Apr 4, 2017 00:32 UTC
BURCAR ALISON DVice President and Gen'l Mgr.
GrantCommon Stock · Derivative 1,535 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001189727-17-000004 · edgardoc.xml · derivative · entry 1

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,535

Underlying: Common Stock · 1,535 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 27, 2017 Filed Jan 21, 2020 19:49 UTC
Woolson DanielVP, GM-Infusion Capital
GrantPerformance Shares · Derivative 727 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001698998-20-000003 · edgardoc.xml · derivative · entry 3

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 727

Underlying: Common Stock · 727 shares

Expires 2019-12-31

F1 · derivative.exercise_date: These PRSUs were granted on March 27, 2017. The vesting for this performance-based restricted stock unit ("PRSU") award was dependent upon the achievement of a minimum Cumulative Adjusted EBITDA over the Fiscal Years 2017-2019. The reporting person was able to earn PRSUs ranging from 100% to 300% of the target award amount.

Read SEC document
March 15, 2017 Filed Mar 16, 2017 21:43 UTC
LOPEZ GEORGE ADirector · 10% owner
PurchaseCommon Stock 12,000 $155.60 $1,867,242.00
Disclosure

SEC source: 0001073397-17-000003 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 577,716

F1 · price: Reflects a weighted-average purchase price of $155.603454 per share, at prices ranging from $155.325 - $155.85.

Read SEC document
March 14, 2017 Filed Mar 14, 2017 22:17 UTC OtherNon-Qualified Stock Option (right to buy) · Derivative 1,500 $37.36 Strike: $37.36 $56,040.00
Disclosure

SEC source: 0001073391-17-000001 · edgardoc.xml · derivative · entry 6

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2019-10-21

F2 · price: Transaction is the exercise of a derivative security; see Column 2.

Read SEC document
March 14, 2017 Filed Mar 14, 2017 22:17 UTC OtherNon-Qualified Stock Option (right to buy) · Derivative 1,500 $32.40 Strike: $32.40 $48,600.00
Disclosure

SEC source: 0001073391-17-000001 · edgardoc.xml · derivative · entry 5

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2020-02-03

F2 · price: Transaction is the exercise of a derivative security; see Column 2.

Read SEC document
March 14, 2017 Filed Mar 14, 2017 22:17 UTC SaleCommon Stock 1,500 $152.20 $228,300.00
Disclosure

SEC source: 0001073391-17-000001 · edgardoc.xml · nonDerivative · entry 4

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,199

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 14, 2017 Filed Mar 14, 2017 22:17 UTC OtherCommon Stock 1,500 $37.36 $56,040.00
Disclosure

SEC source: 0001073391-17-000001 · edgardoc.xml · nonDerivative · entry 3

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,699

Read SEC document
March 14, 2017 Filed Mar 14, 2017 22:17 UTC SaleCommon Stock 1,500 $152.20 $228,300.00
Disclosure

SEC source: 0001073391-17-000001 · edgardoc.xml · nonDerivative · entry 2

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,199

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 14, 2017 Filed Mar 14, 2017 22:17 UTC OtherCommon Stock 1,500 $32.40 $48,600.00
Disclosure

SEC source: 0001073391-17-000001 · edgardoc.xml · nonDerivative · entry 1

SHERMAN RICHARD MD · CIK 0001073391 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,699

Read SEC document
March 13, 2017 Filed Mar 13, 2017 23:09 UTC SaleCommon Stock 646 $155.09 $100,187.88
Disclosure

SEC source: 0001073398-17-000003 · edgardoc.xml · nonDerivative · entry 1

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,644

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 10, 2017 Filed Mar 10, 2017 23:27 UTC SaleCommon Stock 538 $151.26 $81,377.88
Disclosure

SEC source: 0001073398-17-000002 · edgardoc.xml · nonDerivative · entry 3

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,290

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 10, 2017 Filed Mar 10, 2017 23:27 UTC SaleCommon Stock 497 $151.20 $75,146.40
Disclosure

SEC source: 0001073398-17-000002 · edgardoc.xml · nonDerivative · entry 2

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,828

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 10, 2017 Filed Mar 10, 2017 23:27 UTC SaleCommon Stock 200 $151.25 $30,250.00
Disclosure

SEC source: 0001073398-17-000002 · edgardoc.xml · nonDerivative · entry 1

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,325

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 10, 2017 Filed Mar 13, 2017 21:10 UTC
Jain VivekDirector · Chairman and CEO
SaleCommon Stock 12,608 $150.00 $1,891,200.00
Disclosure

SEC source: 0001410442-17-000005 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,946

F1 · security: These shares of common stock were acquired on the open market.

F2 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 09, 2017 Filed Mar 13, 2017 21:10 UTC
Jain VivekDirector · Chairman and CEO
SaleCommon Stock 9,535 $150.00 $1,430,250.00
Disclosure

SEC source: 0001410442-17-000005 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,554

F1 · security: These shares of common stock were acquired on the open market.

F2 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:52 UTC OtherNon-Qualified Stock Option (right to buy) · Derivative 100 $32.07 Strike: $32.07 $3,207.00
Disclosure

SEC source: 0001190251-17-000001 · edgardoc.xml · derivative · entry 6

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100 shares

Expires 2019-02-04

F2 · price: Transaction is the exercise of a derivative security; see Column 2.

F1 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:52 UTC OtherNon-Qualified Stock Option (right to buy) · Derivative 1,400 $32.07 Strike: $32.07 $44,898.00
Disclosure

SEC source: 0001190251-17-000001 · edgardoc.xml · derivative · entry 5

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

Underlying: Common Stock · 1,400 shares

Expires 2019-02-04

F2 · price: Transaction is the exercise of a derivative security; see Column 2.

F1 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:52 UTC SaleCommon Stock 100 $149.60 $14,960.00
Disclosure

SEC source: 0001190251-17-000001 · edgardoc.xml · nonDerivative · entry 4

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,348

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:52 UTC OtherCommon Stock 100 $32.07 $3,207.00
Disclosure

SEC source: 0001190251-17-000001 · edgardoc.xml · nonDerivative · entry 3

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,448

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:52 UTC SaleCommon Stock 1,400 $149.56 $209,377.00
Disclosure

SEC source: 0001190251-17-000001 · edgardoc.xml · nonDerivative · entry 2

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,348

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:52 UTC OtherCommon Stock 1,400 $32.07 $44,898.00
Disclosure

SEC source: 0001190251-17-000001 · edgardoc.xml · nonDerivative · entry 1

SAUCEDO JOSEPH R · CIK 0001190251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,748

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:46 UTC
LOPEZ GEORGE ADirector · 10% owner
OtherNon-Qualified Stock Option (right to buy) · Derivative 40,000 $43.12 Strike: $43.12 $1,724,800.00
Disclosure

SEC source: 0001073397-17-000002 · edgardoc.xml · derivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2021-02-02

F1 · derivative.exercise_price: This transaction was a cash exercise.

F2 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:46 UTC
LOPEZ GEORGE ADirector · 10% owner
OtherNon-Qualified Stock Option (right to buy) · Derivative 15,000 $37.00 Strike: $37.00 $555,000.00
Disclosure

SEC source: 0001073397-17-000002 · edgardoc.xml · derivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2020-07-21

F1 · derivative.exercise_price: This transaction was a cash exercise.

F2 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:46 UTC
LOPEZ GEORGE ADirector · 10% owner
OtherCommon Stock 40,000 $43.12 $1,724,800.00
Disclosure

SEC source: 0001073397-17-000002 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 565,716

Read SEC document
March 08, 2017 Filed Mar 8, 2017 22:46 UTC
LOPEZ GEORGE ADirector · 10% owner
OtherCommon Stock 15,000 $37.00 $555,000.00
Disclosure

SEC source: 0001073397-17-000002 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 525,716

Read SEC document
March 06, 2017 Filed Mar 7, 2017 01:05 UTC
Sanzone Virginia RuthVP, General Counsel
SaleCommon Stock 681 $148.38 $101,044.06
Disclosure

SEC source: 0001669639-17-000002 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: These securities are Restricted Stock Units.

F2 · price: All shares sold were sold at the exact price disclosed.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.